Norbert Bischofberger, Kronos Bio CEO

Dri­ving to the $278M mark on rais­es, a leg­endary R&D ex­pert sets his sights on an­oth­er piv­otal goal line

Think­ing back on his ar­rival at a fledg­ling Kro­nos Bio a lit­tle more than 2 years ago, Nor­bert Bischof­berg­er — oth­er­wise known as em­ploy­ee …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.